Sabo E - Search Results

1

Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection.

Zuckerman E, Slobodin G, Kessel A, Sabo E, Yeshurun D, Halas K, Toubi E. Zuckerman E, et al. Among authors: sabo e. Clin Exp Immunol. 2002 May;128(2):353-8. doi: 10.1046/j.1365-2249.2002.01844.x. Clin Exp Immunol. 2002. PMID: 11985527 Free PMC article.

2

Antiviral treatment down-regulates peripheral B-cell CD81 expression and CD5 expansion in chronic hepatitis C virus infection.

Zuckerman E, Kessel A, Slobodin G, Sabo E, Yeshurun D, Toubi E. Zuckerman E, et al. Among authors: sabo e. J Virol. 2003 Oct;77(19):10432-6. doi: 10.1128/jvi.77.19.10432-10436.2003. J Virol. 2003. PMID: 12970428 Free PMC article.

3

Enhanced apoptosis of peripheral CD5-negative B lymphocytes from chronically hepatitis C virus-infected patients: reversal after antiviral treatment.

Toubi E, Kessel A, Peri R, Shmuel Z, Bamberger E, Sabo E, Zuckerman E. Toubi E, et al. Among authors: sabo e. J Virol. 2004 Oct;78(20):11379-84. doi: 10.1128/JVI.78.20.11379-11384.2004. J Virol. 2004. PMID: 15452259 Free PMC article.

4

IVIg attenuates TLR-9 activation in B cells from SLE patients.

Kessel A, Peri R, Haj T, Snir A, Slobodin G, Sabo E, Rosner I, Shoenfeld Y, Toubi E. Kessel A, et al. Among authors: sabo e. J Clin Immunol. 2011 Feb;31(1):30-8. doi: 10.1007/s10875-010-9469-3. Epub 2010 Oct 5. J Clin Immunol. 2011. PMID: 20922561

5

Immune aberrations in B and T lymphocytes derived from chronic urticaria patients.

Toubi E, Adir-Shani A, Kessel A, Shmuel Z, Sabo E, Hacham H. Toubi E, et al. Among authors: sabo e. J Clin Immunol. 2000 Sep;20(5):371-8. doi: 10.1023/a:1006624331022. J Clin Immunol. 2000. PMID: 11051279

6

Enhanced peripheral T-cell apoptosis in chronic hepatitis C virus infection: association with liver disease severity.

Toubi E, Kessel A, Goldstein L, Slobodin G, Sabo E, Shmuel Z, Zuckerman E. Toubi E, et al. Among authors: sabo e. J Hepatol. 2001 Dec;35(6):774-80. doi: 10.1016/s0168-8278(01)00207-0. J Hepatol. 2001. PMID: 11738105

7

The association of serum matrix metalloproteinases and their tissue inhibitor levels with scleroderma disease severity.

Toubi E, Kessel A, Grushko G, Sabo E, Rozenbaum M, Rosner I. Toubi E, et al. Among authors: sabo e. Clin Exp Rheumatol. 2002 Mar-Apr;20(2):221-4. Clin Exp Rheumatol. 2002. PMID: 12051403

8

Increased plasma levels of matrix metalloproteinase-9 are associated with the severity of chronic urticaria.

Kessel A, Bishara R, Amital A, Bamberger E, Sabo E, Grushko G, Toubi E. Kessel A, et al. Among authors: sabo e. Clin Exp Allergy. 2005 Feb;35(2):221-5. doi: 10.1111/j.1365-2222.2005.02168.x. Clin Exp Allergy. 2005. PMID: 15725195

9

Quantitative liver-spleen scan using single photon emission computerized tomography (SPECT) for assessment of hepatic function in cirrhotic patients.

Zuckerman E, Slobodin G, Sabo E, Yeshurun D, Naschitz JE, Groshar D. Zuckerman E, et al. Among authors: sabo e. J Hepatol. 2003 Sep;39(3):326-32. doi: 10.1016/s0168-8278(03)00296-4. J Hepatol. 2003. PMID: 12927917 Clinical Trial.

10

Increased CD8+ T cell apoptosis in scleroderma is associated with low levels of NF-kappa B.

Kessel A, Rosner I, Rozenbaum M, Zisman D, Sagiv A, Shmuel Z, Sabo E, Toubi E. Kessel A, et al. Among authors: sabo e. J Clin Immunol. 2004 Jan;24(1):30-6. doi: 10.1023/B:JOCI.0000018060.36183.bb. J Clin Immunol. 2004. PMID: 14997031

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

324 results

Search Page

Filters